Sandy Joaquina

T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours

Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber et al. · Nature Biomedical Engineering · 2021 · 175 citations · Full text

Medicine, Immunology, Oncology +16

CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1

Chahrazade Kantari‐Mimoun, Sarah Barrin, Lene Vimeux et al. · Cancer Immunology Research · 2021 · 70 citations · Full text

Life Sciences, Immunology, Oncology +15

CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1.

Chahrazade Kantari‐Mimoun, Sarah Barrin, Lene Vimeux et al. · PubMed · 2021 · 47 citations

Life Sciences, Immunology, Oncology +15

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

Nadia Mensali, Hakan Köksal, Sandy Joaquina et al. · Nature Communications · 2023 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +17

CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia

Benjamin Caulier, Sandy Joaquina, Pascal Gélébart et al. · Cell Reports Medicine · 2024 · 19 citations · Full text

Medicine, Hematology, Oncology +17